1. Home
  2. MRSN vs UONEK Comparison

MRSN vs UONEK Comparison

Compare MRSN & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • UONEK
  • Stock Information
  • Founded
  • MRSN 2001
  • UONEK 1980
  • Country
  • MRSN United States
  • UONEK United States
  • Employees
  • MRSN N/A
  • UONEK N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • UONEK Broadcasting
  • Sector
  • MRSN Health Care
  • UONEK Consumer Discretionary
  • Exchange
  • MRSN Nasdaq
  • UONEK Nasdaq
  • Market Cap
  • MRSN 34.0M
  • UONEK 28.1M
  • IPO Year
  • MRSN 2017
  • UONEK N/A
  • Fundamental
  • Price
  • MRSN $6.75
  • UONEK $0.63
  • Analyst Decision
  • MRSN Strong Buy
  • UONEK
  • Analyst Count
  • MRSN 5
  • UONEK 0
  • Target Price
  • MRSN $5.75
  • UONEK N/A
  • AVG Volume (30 Days)
  • MRSN 130.5K
  • UONEK 297.2K
  • Earning Date
  • MRSN 08-12-2025
  • UONEK 08-19-2025
  • Dividend Yield
  • MRSN N/A
  • UONEK N/A
  • EPS Growth
  • MRSN N/A
  • UONEK N/A
  • EPS
  • MRSN N/A
  • UONEK N/A
  • Revenue
  • MRSN $34,006,000.00
  • UONEK $437,499,000.00
  • Revenue This Year
  • MRSN N/A
  • UONEK N/A
  • Revenue Next Year
  • MRSN $1.03
  • UONEK N/A
  • P/E Ratio
  • MRSN N/A
  • UONEK N/A
  • Revenue Growth
  • MRSN N/A
  • UONEK N/A
  • 52 Week Low
  • MRSN $6.47
  • UONEK $0.44
  • 52 Week High
  • MRSN $70.75
  • UONEK $1.51
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 38.74
  • UONEK 47.72
  • Support Level
  • MRSN $6.55
  • UONEK $0.57
  • Resistance Level
  • MRSN $10.25
  • UONEK $0.70
  • Average True Range (ATR)
  • MRSN 0.70
  • UONEK 0.10
  • MACD
  • MRSN -0.20
  • UONEK -0.00
  • Stochastic Oscillator
  • MRSN 5.41
  • UONEK 20.70

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: